Eterna Therapeutics Inc. (NASDAQ:ERNA) Short Interest Update

Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the target of a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 97,900 shares, a decline of 6.6% from the July 31st total of 104,800 shares. Approximately 3.2% of the company’s shares are sold short. […]

Related Keywords

,Renaissance Technologies ,Geode Capital Management ,Eterna Therapeutics Inc ,Ci Private Wealth ,Goldman Sachs Group Inc ,Nasdaq ,Eterna Therapeutics ,Get Free Report ,Sachs Group ,Capital Management ,Capital Advisors ,Therapeutics Inc ,Eterna Therapeutics Daily ,Nasdaq Erna ,Derna ,Medical ,Stocks ,Options ,Put ,Call ,